Abstract
Purpose
To examine the effects of ascorbic acid (AA) administrated during cardiopulmonary resuscitation (CPR) on the myocardial injury in a rat model of ventricular fibrillation (VF) and electrical shock (ES).
Methods
VF was induced in male Wistar rats and left untreated for 5 min, followed by 1 min of CPR, and then one ES of 5 J. At the start of CPR, animals received either intravenous administration of AA (100 mg/kg) or Tempol (30 mg/kg), two antioxidants, or 0.9% saline (VF + ES group). After ES, animals were immediately killed. Myocardial lipoxidation was determined by malondialdehyde (MDA) assay. The histology and ultrastructural changes of myocardium were also evaluated. The mitochondrial permeability transition pore (mPTP) opening was measured based on the mitochondrial swelling rate. The complex activities and respiration of mitochondria were assessed, too.
Results
Increased myocardial injury and mitochondrial damage in the VF + ES group were noted. AA and Tempol alleviated such damages. Both AA and Tempol improved accelerated mitochondrial swelling; decreased complex activities and respiratory dysfunction occurred in the VF + ES group. The animals receiving AA and Tempol during CPR had better successful resuscitation rates and 72-h survival than the VF + ES group.
Conclusions
Intravenous administration of AA and Tempol at the start of CPR may reduce lipid peroxidation and myocardial necrosis, diminish mitochondrial damage, facilitate resuscitation, and improve outcomes after VF + ES.
Similar content being viewed by others
References
Peatfield RC, Sillett RW, Taylor D, McNicol MW (1997) Survival after cardiac arrest in the hospital. Lancet 1:1223–1225
Schenenberger RA, von Planta M, von Planta I (1994) Survival after failed out of hospital resuscitation. Are further therapeutic efforts in the emergency department futile? Arch Intern Med 154:2433–2437
Gazmuri RJ, Berkowitz M, Cajigas H (1999) Myocardial effects of ventricular fibrillation in the isolated rat heart. Crit Care Med 27:1542–1550
Xie J, Weil MH, Sun S, Tang W, Sato Y, Jin X, Bisera J (1997) High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 96:683–688
Krauthamer V, Jones JL (1997) Calcium dynamics in cultured heart cells exposed to defibrillator-type electrical shocks. Life Sci 60:1977–1985
Caterine MR, Spencer KT, Pagan-Carlo LA, Smith RS, Buettner GR, Kerber RE (1996) Direct current shocks to the heart generate free radicals: an electron paramagnetic resonance study. J Am Coll Cardiol 28:1598–1609
Weaver WD, Cobb LA, Copass MK, Hallstrom AP (1982) Ventricular defibrillation—a comparative trial using 175-J and 320-J shocks. N Engl J Med 307:1101–1106
Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck KH, Gent M, Connolly SJ (2010) Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the defibrillation in acute myocardial infarction trial (DINAMIT). Circulation 122:2645–2652
Zhang Y, Boddicker KA, Rhee BJ, Davies LR, Kerber RE (2005) Effect of nitric oxide synthase modulation on resuscitation success in a swine ventricular fibrillation cardiac arrest model. Resuscitation 67:127–134
Tsai MS, Sun S, Tang W, Ristagno G, Chen WJ, Weil MH (2008) Free radicals mediate postshock contractile impairment in cardiomyocytes. Crit Care Med 36:3213–3219
Woodward B, Zakaria MN (1985) Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 17:485–493
Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ, El-Sokkary GH (1998) Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 25:184–191
Karahaliou A, Katsouras C, Koulouras V, Nikas D, Niokou D, Papadopoulos G, Nakos G, Sideris D, Michalis L (2008) Ventricular arrhythmias and antioxidative medication: experimental study. Hellenic J Cardiol 49:320–328
Senthil S, Veerappan RM, Ramakrishna Rao M, Pugalendi KV (2004) Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clin Chim Acta 348:131–137
Gao F, Yao CL, Gao E, Mo QZ, Yan WL, McLaughlin R, Lopez BL, Christopher TA, Ma XL (2002) Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther 301:543–550
Johnston CS, Cox SK (2001) Plasma-saturating intakes of vitamin C confer maximal antioxidant protection to plasma. J Am Coll Nutr 20:623–627
Huang CH, Hsu CY, Tsai MS, Wang TD, Chang WT, Chen WJ (2008) Cardioprotective effects of erythropoietin on postresuscitation myocardial dysfunction in appropriate therapeutic windows. Crit Care Med 36:S467–S473
Sodha NR, Boodhwani M, Ramlawi B, Clements RT, Mieno S, Feng J, Xu SH, Bianchi C, Sellke FW (2008) Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia. J Card Surg 23:312–320
Shiva S, Brookes PS, Patel RP, Anderson PG, Darley-Usmar VM (2001) Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc Natl Acad Sci USA 98:7212–7217
Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M (2005) Postconditioning inhibits mitochondrial permeability transition. Circulation 111:194–197
Chowdhury SK, Drahota Z, Floryk D, Calda P, Houstek J (2000) Activities of mitochondrial oxidative phosphorylation enzymes in cultured amniocytes. Clin Chim Acta 298:157–173
Di Maria CA, Bogoyevitch MA, McKitrick DJ, Arnolda LF, Hool LC, Arthur PG (2009) Changes in oxygen tension affect cardiac mitochondrial respiration rate via changes in the rate of mitochondrial hydrogen peroxide production. J Mol Cell Cardiol 47:49–56
Murphy MP (2001) How understanding the control of energy metabolism can help investigation of mitochondrial dysfunction, regulation and pharmacology. Biochim Biophys Acta 1504:1–11
Trouton TG, Allen JD, Yong LK, Rooney JJ, Adgey AA (1989) Metabolic changes and mitochondrial dysfunction early following transthoracic countershock in dogs. Pacing Clin Electrophysiol 12:1827–1834
Rigoulet M, Yoboue ED, Devin A (2011) Mitochondrial ROS generation and its regulation mechanisms involved in H2O2 signaling. Antioxid Redox Signal 14:459–468
Jackson CV, Mickelson JK, Stringer K, Rao PS, Lucchesi BR (1986) Electrolysis-induced myocardial dysfunction. A novel method for the study of free radical mediated tissue injury. J Pharmacol Methods 15:305–320
Schrier GM, Hess ML (1988) Quantitative identification of superoxide anion as a negative inotropic species. Am J Physiol 255:H138–H143
Xu KY, Zweier JL, Becker LC (1997) Hydroxyl radical inhibits sarcoplasmic reticulum Ca2+-ATPase function by direct attack on the ATP binding site. Circ Res 80:76–81
Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233–249
Crompton M, Virji S, Doyle V, Johnson N, Ward JM (1999) The mitochondrial permeability transition pore. Biochem Soc Symp 66:167–179
Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion–a target for cardioprotection. Cardiovasc Res 61:372–385
Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM (2002) Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55:534–543
O’Rourke B (2004) Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res 94:420–432
Suleiman MS, Halestrap AP, Griffiths EJ (2001) Mitochondria: a target for myocardial protection. Pharmacol Ther 89:29–46
Sönmez MF, Narin F, Akkuş D, Ozdamar S (2009) Effect of melatonin and vitamin C on expression of endothelial NOS in heart of chronic alcoholic rats. Toxicol Ind Health 25:385–393
Korantzopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E, Siogas K, Goudevenos JA (2005) Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102:321–326
Acknowledgments
We are grateful to Prof. Kuo-Shyan Lu, Dr. Pei-Hsin Huang, Yu-Jen Su, and Shu-mei Lai for their assistance. The study was supported by a research grant from the Taiwan National Science Council.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tsai, MS., Huang, CH., Tsai, CY. et al. Ascorbic acid mitigates the myocardial injury after cardiac arrest and electrical shock. Intensive Care Med 37, 2033–2040 (2011). https://doi.org/10.1007/s00134-011-2362-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-011-2362-6